| Reference (year) | Study design | Participants T/C | Intervention (herbs included) | Control | Outcome measure | Treatment duration (days) |
|
Cao (2013) [18] | RCT | 36/36 | LDP treatment (6 g, bid) plus acarbose (100 mg, tid) | Acarbose (100 mg, tid) | 24 h UTP; FBG; PBG; UmAlb | 60 |
| Lou (2014) [32] | RCT | 60/60 | LDP treatment (8 pills, tid) plus telmisartan (80 mg, qd) plus routine treatment | Telmisartan (80 mg, qd) plus routine treatment | 24 h UTP | 360 |
|
Li and Zhao (2011) [26] | RCT | 30/30 | LDP treatment (8 pills, tid) plus routine treatment | Routine treatment | UAER | 90 |
| He et al. (2009) [20] | RCT | 17/18 | LDP treatment (8 pills, tid) plus Benazepril Hydrochloride (10 mg, qd) | Benazepril Hydrochloride (10 mg, qd) | 24 h UTP | 90 |
| Song et al. (2004) [28] | RCT | 41/31 | LDP treatment (9 g, tid) plus routine treatment | Routine treatment | FBG, PBG, UAER | 90 |
|
Chen and Ling (2004) [15] | RCT | 38/30 | LDP treatment (6 g, tid) plus captopril (12.5 mg, tid) plus routine treatment | Captopril (12.5 mg, tid) plus routine treatment | UAER | 90 |
| Liu (2012) [21] | RCT | 30/30 | LDP treatment (9 g, bid) plus routine treatment | Routine treatment | BUN, Scr | 60 |
|
Kong and Zeng (2014) [17] | RCT | 25/25 | LDP treatment (8 pills, tid) plus routine treatment | Routine treatment | FBG, PBG, HbA1c | 360 |
| Chen et al. (2009) [23] | RCT | 34/34 | LDP treatment (10 g, bid) plus routine treatment | Routine treatment | UAER, FBG, BUN, Scr | 60 |
|
Wang (2015) [24] | RCT | 50/50 | LDP treatment (9 g, bid) plus Losartan Potassium (50 mg, qd) | Losartan Potassium tablets (50 mg, qd) | Scr, BUN, UmAlb, UAER | 56 |
| Wang et al. (2013) [16] | RCT | 33/30 | LDP treatment (6 g, bid) plus valsartan dispersible (80 mg, qd) plus routine treatment | Valsartan dispersible (80 mg, qd) plus routine treatment | UAER, UmAlb | 28 |
| Yin et al. (2010) [29] | RCT | 17/17 | LDP treatment (6 g, bid) plus routine treatment | Routine treatment | FBG, UmAlb | 56 |
|
Li (2013) [22] | RCT | 37/38 | LDP treatment (8 pills, tid) plus enalapril (5 mg, bid) | Enalapril (5 mg, bid) | FBG, UmAlb, HbA1c | 42 |
| Zhong et al. (2010) [30] | RCT | 21/21 | LDP treatment (6 g, bid) plus routine treatment | Routine treatment | Scr | 21 |
|
Zhao (2010) [25] | RCT | 30/30 | LDP treatment (8 pills, tid) plus routine treatment | Routine treatment | 24 h UTP | 90 |
| Ma (2015) [31] | RCT | 74/74 | LDP treatment (8 pills, tid) plus Losartan Potassium (50 mg, qd) | Losartan Potassium tablets (50 mg, qd) | UAER, Scr, BUN | 180 |
| Deng et al. (2006) [19] | RCT | 22/22 | LDP treatment (10 g, tid) plus Perindopril (2 mg, qd) plus routine treatment | Perindopril (2 mg, qd) plus routine treatment | UmAlb | 56 |
|
Lv and Wang (2006) [27] | RCT | 45/41 | LDP treatment (8 pills, tid) plus routine treatment | Routine treatment | 24 h UTP, UAER, Scr | 112 |
|
|